Paper8085162
Molecular determinants of state-dependent block of Na+ channels by local anesthetics.
Ragsdale DS and 3 others. Science, 1994. Cited by 699 papers, by iCite.
Cite this record
ConductScience Library. Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Papers, record 8085162. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8085162
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anesthetics, Local | Major topic |
| Etidocaine | Major topic |
| Sodium Channels | Major topic |
| Action Potentials | |
| Animals | |
| Binding Sites | |
| Lidocaine | |
| Mutagenesis, Site-Directed | |
| Oocytes | |
| Rats | |
| Xenopus |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01-HL44948 | NHLBI NIH HHS | United States | P01HL044948 | PubMed and NIH | NIH RePORTER |
| R01-NS15751 | NINDS NIH HHS | United States | R01NS015751 | PubMed and NIH | NIH RePORTER |
Cited by320
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 699 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42604906 | Quantum Methods in Drug Discovery: An Introduction to the Theoceptor (Theoretical Receptor) Approach. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/42604906 | PubMed |
| 42453418 | Acquired pharmacoresistance in temporal lobe epilepsy is driven by Nav1.6-mediated subicular hyperexcitability. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42453418 | PubMed |
| 41897281 | Alteration of Lipid Bilayer Electrical Potential by Phytochemicals and Synthetic Analogs: Implications for Cellular Function. | Biomolecules | 2026 | https://conductscience.org/library/papers/41897281 | PubMed |
| 41869747 | Alternative splicing in voltage-gated sodium channels: mechanisms, regulatory networks and therapeutic implications. | Ann Med | 2026 | https://conductscience.org/library/papers/41869747 | PubMed |
| 41667447 | Molecular determinant of low-voltage dependence of human Nav1.7 inactivation revealed by efficacy-based Nav1.7 selective inhibitor. | Nat Commun | 2026 | https://conductscience.org/library/papers/41667447 | PubMed |
| 41565997 | The psychoactive cannabinoid THC inhibits peripheral nociceptors by targeting NaV1.7 and NaV1.8 nociceptive sodium channels. | Neuropsychopharmacology | 2026 | https://conductscience.org/library/papers/41565997 | PubMed |
| 40830395 | Sevoflurane inhibition of the developmentally expressed neuronal sodium channel Nav1.3. | Sci Rep | 2025 | https://conductscience.org/library/papers/40830395 | PubMed |
| 40710539 | (-)-Epigallocatechin-3-Gallate Suppresses Hyperexcitability in Rat Primary Nociceptive Neurons Innervating Inflamed Tissues: A Comparison with Lidocaine. | Metabolites | 2025 | https://conductscience.org/library/papers/40710539 | PubMed |
| 40528706 | The Chemistry and Biology of the Tetrodotoxin Natural Product Family. | Angew Chem Int Ed Engl | 2025 | https://conductscience.org/library/papers/40528706 | PubMed |
| 40528032 | Neuroinflammation leads to pharmacoresistance in temporal lobe epilepsy via promoting spermine degradation. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/40528032 | PubMed |
| 40465624 | The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40465624 | PubMed |
| 40371334 | Inhibition of NMDA receptors and other ion channel types by membrane-associated drugs. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40371334 | PubMed |
| 40365421 | Design, Synthesis, and Evaluation of Sodium Channel Blockers with Anti-invasive Activities in Medullary Thyroid Cancer. | ACS Med Chem Lett | 2025 | https://conductscience.org/library/papers/40365421 | PubMed |
| 40054693 | Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillation. | J Biol Chem | 2025 | https://conductscience.org/library/papers/40054693 | PubMed |
| 39796214 | Differential Inhibition by Cenobamate of Canonical Human Nav1.5 Ion Channels and Several Point Mutants. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39796214 | PubMed |
| 39796059 | Flecainide Specifically Targets the Monovalent Countercurrent Through the Cardiac Ryanodine Receptor, While a Dominant Opposing Ca2+/Ba2+ Current Is Present. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39796059 | PubMed |
| 39774837 | Drugs exhibit diverse binding modes and access routes in the Nav1.5 cardiac sodium channel pore. | J Gen Physiol | 2025 | https://conductscience.org/library/papers/39774837 | PubMed |
| 39766288 | Inhibitory Effects of Cenobamate on Multiple Human Cardiac Ion Channels and Possible Arrhythmogenic Consequences. | Biomolecules | 2024 | https://conductscience.org/library/papers/39766288 | PubMed |
| 39195887 | New insights on cardiac Na channel block by an atypical anti-arrhythmic drug. | Nat Cardiovasc Res | 2023 | https://conductscience.org/library/papers/39195887 | PubMed |
| 39185478 | Structural basis for inhibition of the cardiac sodium channel by the atypical antiarrhythmic drug ranolazine. | Nat Cardiovasc Res | 2023 | https://conductscience.org/library/papers/39185478 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8085162
GET https://conductscience.org/api/papers/v1/8085162/cited_by?page=2